Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes.
Barba T, Harb J, Ducreux S, Koenig A, Mathias V, Rabeyrin M, Pouliquen E, Sicard A, Chartoire D, Dugast E, Defrance T, Morelon E, Brouard S, Dubois V, Thaunat O.
Barba T, et al. Among authors: thaunat o.
Front Immunol. 2019 Mar 20;10:513. doi: 10.3389/fimmu.2019.00513. eCollection 2019.
Front Immunol. 2019.
PMID: 30949173
Free PMC article.